MENU
VTVT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
vTv Therapeutics (VTVT) Ownership - Who owns vTv Therapeutics?
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3980 Premier Drive
Phone
+1 336 841-0300
Employees
16
Web
https://www.vtvtherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.92M
P/E Ratio
N/A
Total Cash
31.06M
Projected Growth
N/A
Total Debt
125K
Revenue
17K
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash/Share
11.87
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
VTVT
Capitalization
37.9M
P/E Ratio
N/A
Risk (Beta)
0.46
Dividend Yield
N/A
Total Cash
31.1M
Total Cash/Share
11.87
Total Debt
125K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
17K
ROE
N/A
Book Value
7.92M
P/B Ratio
4.79
Cash Flow
N/A
Earnings
-2.8
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
32K
Current Ratio
7.39
Current Revenue Per Employee
1062.50
Dividends Per Share - Security
N/A
EBITDA
-23.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.36
Shares Held By Institutions
14.5M
Shares Outstanding - Current
2.62M
Total Liabilities
23.1M
Total Volume MTD
N/A
Value
-1
Gain YTD
4.934
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage pharmaceutical holding company, which focuses on the discovery and development of human therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3980 Premier Drive
Phone
+1 336 841-0300
Employees
16
Web
https://www.vtvtherapeutics.com